Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Pharmacol. 2013 Apr;13(2):210-7. doi: 10.1016/j.coph.2013.01.001. Epub 2013 Jan 25.

Coronary artery disease and ventricular tachyarrhythmia: pathophysiology and treatment.

Author information

1
Department of Cardiology, University of Ioannina, Greece. thkolet@cc.uoi.gr

Abstract

Ventricular tachyarrhythmias are common consequences of coronary artery disease. During the prehospital phase of acute myocardial infarction (MI), ischemia-induced electrophysiological changes and genetic factors are responsible for their occurrence, but the precise pathophysiologic mechanisms are ill-understood. Primary percutaneous coronary interventions (PCIs) have decreased the incidence of ventricular tachyarrhythmias during subsequent stages, and future treatments ameliorating reperfusion injury may provide further progress. In the chronic phase, antiarrhythmic drug therapy targeted toward arrhythmogenic substrate has relatively limited value, but alternative approaches are still uncertain. By contrast, prompt arrhythmia termination by implantable cardioverter-defibrillators (ICDs) is highly effective, although risk-stratification algorithms in candidate patients are inadequate. This review explores current views in the pathophysiology and treatment of ventricular tachyarrhythmias at different clinical stages.

PMID:
23357129
DOI:
10.1016/j.coph.2013.01.001
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center